The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTetragon Fin Regulatory News (TFG)

Share Price Information for Tetragon Fin (TFG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.70
Bid: 9.50
Ask: 9.90
Change: 0.05 (0.52%)
Spread: 0.40 (4.211%)
Open: 9.65
High: 9.70
Low: 9.65
Prev. Close: 9.65
TFG Live PriceLast checked at -
Tetragon Financial Group is an Investment Trust

To generate distributable income and capital appreciation by investing in a broad range of assets, with the aim of providing stable returns to investors across various credit, equity, interest rate, inflation and real estate cycles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of a Tender Offer

8 Dec 2023 07:00

Tetragon Financial Group Ltd - Notification of a Tender Offer

Tetragon Financial Group Ltd - Notification of a Tender Offer

PR Newswire

LONDON, United Kingdom, December 08

Tetragon Financial Group Limited Announcement of Final Results of Tender Offer to Purchase Tetragon Non-Voting Shares

LONDON, Dec. 8, 2023 -- Tetragon announces the final results of the "modified Dutch auction" tender offer to purchase a portion of the outstanding non-voting shares of Tetragon for a maximum aggregate payment of $35,000,000 in cash. The tender offer expired at 11:59 p.m. (ET) on 6 December 2023.

J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove) acted as dealer manager for the tender offer and Computershare Investor Services PLC acted as tender agent for the tender offer. As dealer manager, J.P. Morgan determined the final purchase price at which Tetragon will purchase shares in the tender offer. As tender agent, Computershare determined the final proration factor.

In accordance with the terms of the tender offer, Tetragon has accepted for purchase 3,414,623 non-voting shares at a purchase price of $10.25 per share. The aggregate cost of this purchase is $34,999,885.75, excluding fees and expenses relating to the tender offer. A total of 4,744,038 Tetragon non-voting shares were properly tendered and not properly withdrawn at or below the purchase price of $10.25 per share. Because more than $35,000,000 in value of Tetragon non-voting shares was properly tendered and not properly withdrawn, the tender offer was subject to proration pursuant to the terms of the tender offer, with appropriate adjustments to avoid purchases of fractional shares. The final proration factor, which is applicable only to shares properly tendered and not properly withdrawn at the purchase price of $10.25 per share, is 27.75%, rounded to the second decimal place.1

Tetragon will promptly make payment for the shares validly tendered and accepted for purchase, which is expected to occur on or about 12 December 2023. All shares tendered and not purchased in the tender offer will be promptly returned to the tendering shareholders.

About Tetragon:

Tetragon is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the Main Market of the London Stock Exchange. Our investment manager is Tetragon Financial Management LP. Find out more at www.tetragoninv.com.

Tetragon's non-voting shares are subject to restrictions on ownership by U.S. persons and are not intended for European retail investors.

Please see: https://www.tetragoninv.com/shareholders/additional-information.

_______________________________
1 The full final proration factor applied is 27.75123543711350%.
Tetragon:Press Inquiries:
Yuko ThomasProsek Partners
Investor RelationsPro-tetragon@prosek.com
ir@tetragoninv.com+44 20 3890 9193
+1 212 279 3115

This release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (2014/596/EU), or EU MAR, and of the UK version of EU MAR as it forms part of UK law by virtue of the European Union (Withdrawal) Act (as amended).

This release does not contain or constitute an offer to sell or a solicitation of an offer to purchase securities in the United States or any other jurisdiction. The securities of Tetragon have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States or to U.S. persons unless they are registered under applicable law or exempt from registration. Tetragon does not intend to register any portion of its securities in the United States or to conduct a public offer of securities in the United States. In addition, Tetragon has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended, and investors will not be entitled to the benefits of such Act. Tetragon is registered in the public register of the Netherlands Authority for the Financial Markets (Autoriteit Financiële Markten) under Section 1:107 of the Dutch Financial Markets Supervision Act as an alternative investment fund from a designated state.

J.P. Morgan Securities plc, which is authorised by the UK Prudential Regulation Authority and regulated by the UK Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively for Tetragon and for no one else in connection with the tender offer and will not be responsible to anyone (whether or not recipient of the tender offer) other than Tetragon for providing the protections afforded to the clients of J.P. Morgan Securities plc or for providing advice in relation to the tender offer.



Date   Source Headline
16th Apr 202412:07 pmEQSEdison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors
11th Apr 20245:30 pmPRNNotification of a Tender Offer
28th Mar 20246:55 amPRNStatement re: Monthly Factsheet
18th Mar 20246:30 pmPRNTetragon Financial Group Limited U.S. Shareholders Tax Reporting Information
13th Mar 20242:00 pmPRNStatement re: Dividend Information
8th Mar 20247:45 amPRNNotification of a Tender Offer
4th Mar 20247:31 pmPRNAnnual Financial Report
4th Mar 20247:31 pmPRNDividend Declaration
29th Feb 20247:00 amPRNStatement re: Monthly Factsheet
20th Feb 20247:00 amPRNStatement re: investor call
31st Jan 20247:00 amPRNStatement re: Monthly Factsheet
29th Dec 20236:55 amPRNStatement re: Monthly Factsheet
15th Dec 20237:00 amPRNTetragon Financial Group Limited Annual General Meeting
8th Dec 20237:00 amPRNNotification of a Tender Offer
30th Nov 20237:00 amPRNStatement re: Monthly Factsheet
9th Nov 20237:00 amPRNStatement re: Dividend Information
3rd Nov 20235:06 pmPRNNotification of a Tender Offer
31st Oct 20237:00 amPRNStatement re: Monthly Factsheet
26th Oct 20237:00 amPRNDividend Declaration
29th Sep 20237:00 amPRNStatement re: Monthly Factsheet
31st Aug 20237:00 amPRNStatement re: Monthly Factsheet
11th Aug 20237:15 amRNSEdison issues update on Tetragon Financial Group
9th Aug 202312:13 pmPRNStatement re: Dividend Information
1st Aug 20238:50 amPRNTetragon Financial Group Limited Announcement of Dividend
1st Aug 20238:49 amPRNTetragon Financial Group Limited 2023 Half Yearly Report
31st Jul 20237:00 amPRNStatement re: Monthly Factsheet
18th Jul 20237:00 amPRNInvestor Call
30th Jun 20236:55 amPRNStatement re: Monthly Factsheet
19th Apr 20237:15 amRNSEdison issues review on Tetragon Financial Group
24th Nov 202211:57 amRNSEdison issues review on Tetragon LP (TFG)
30th Aug 20228:37 amRNSEdison issues review on Tetragon Financial Group
29th Jun 202211:00 amRNSEdison issues outlook on Tetragon Financial Group
29th Jun 202210:53 amEQSTetragon Financial Group (TFG): Offering a diverse exposure to alternative assets
31st May 20227:00 amPRNStatement re Monthly Factsheet
11th Apr 20227:00 amPRNFinal Results to Purchase Tetragon Non-Voting Shares
31st Mar 20227:00 amPRNStatement re Monthly Factsheet
22nd Mar 20225:00 pmPRNLimited U.S. Shareholders Tax Reporting Information
15th Mar 202212:53 pmPRNStatement re Dividend Information
10th Mar 20227:00 amPRNNotification of a Tender Offer
7th Mar 20227:00 amPRNDividend and Tender Offer Declaration
7th Mar 20227:00 amPRNAnnual Financial Report
28th Feb 20227:00 amPRNStatement re: Monthly Factsheet
21st Feb 20225:00 pmPRNInvestor call
31st Jan 20227:00 amPRNStatement re Monthly Factsheet
31st Dec 20217:00 amPRNStatement re: Monthly Factsheet
17th Dec 20217:00 amPRNNotice of AGM
16th Dec 20217:00 amRNSEdison issues review on Tetragon Financial Group
30th Nov 20217:00 amPRNStatement re: Monthly Factsheet
8th Nov 20212:15 pmPRNStatement re: Dividend Information
29th Oct 20217:00 amPRNStatement re: Monthly Factsheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.